Minoxidil (Regaine)

Please note the contents of this page is intended as general information and should not be considered medical advice. For more information please Click here.
Minoxidil (Rogaine) Treatment

Minoxidil can be suitable for the treatment of both male and female pattern hair loss. It has been clinically proven to slow down and even stop hair loss in some cases, and to help regrow hair on the vertex (crown) in others. Minoxidil can be used as either a topical solution (Regaine) or an oral tablet.

Topical Minoxidil (Regaine)

Topical Minoxidil received  U.S. Food and Drug Administration (FDA) approval for male pattern hair loss in 1988 and for female pattern hair loss in 1992. It is the first medication for application to the scalp that has been proven to grow human hair. To remain effective topical Minoxidil must be used on a daily basis and can be bought from pharmacies without a prescription.

Regaine is the brand name for the topically applied Minoxidil solution which can be purchased over-the-counter in either a 2% or 5% solution. It appears that the 5% solution is approximately 50% more effective than the 2% solution. The greatest benefit from the medication is seen from 5 months to 2 years, with a gradual decrease in effectiveness after that. Evidence has also shown that using Regaine at night can be more effective than its use in the daytime.

Oral Minoxidil

Oral minoxidil is a medication that was initially developed in the 1950’s and was approved by the FDA for the treatment of hypertension in 1979. It was first noticed to improve hair loss in men in 1980.

In recent years, there has been a renewed interest in utilising oral minoxidil at low dose to treat androgenetic alopecia (pattern hair loss). Studies have shown significant increases in hair density in this condition with its use and it has also been shown to help with hair loss after chemotherapy.  While oral minoxidil is generally well tolerated at low dose, like most medications side effects can be experienced and so it’s prescription should be supervised by a physician experienced in its use. These most commonly include:

  • Position related light-headedness (due to its effect on blood pressure)
  • Palpitations
  • Fluid retention
  • Increase in body/facial hair

For more information on oral minoxidil visit: https://www.medicines.org.uk/emc/product/4294/smpc

Although the mechanism by which Minoxidil stimulates hair growth is not known, it probably works by prolonging the hair follicle growth cycle. The effect of the medication is to increase the quality of the hair by increasing the diameter and length of miniaturized (fine) hair. Most patients who do grow hair grow only short, thin fuzz, “peach hair”. It does not grow hair in areas that are bald. It appears that Minoxidil’s effects may only be temporary. Once the drug is stopped, the previous pattern of hair loss resumes, and any effects are lost within 2 to 3 months, even if the medication had been used for many years. This same limitation applies to other drugs used for hair loss.

With time, patients using Minoxidil continue to bald, although at a somewhat slower rate.

The concomitant use in men of Minoxidil and the only other FDA approved drug for treating hair loss is often considered as there appears to be a synergy between these 2 medications. That is, they treat hair loss in a different but complementary way.

Use in women

The early studies with Minoxidil were on balding men, but it appears that Minoxidil may actually be more effective in women. In fact, Minoxidil in its topical form is the only FDA approved medication for women with hair loss.

While all cases are different and require expert assessment, oral Minoxidil can be considered for female patients. A recent study in women aged 18 to 80 (mean aged 48.44 years) demonstrated a reduction in hair loss severity and shedding at 6 months and 12 months with its use.

 

 

 

About the Author

Maurice Collins

DR Maurice Collins

Consultant Surgeon
MB, B.Ch, BAO, DLO, FRCSI, FRCS, FRCSEd.
Registered with the Medical Council of Ireland

Dr Collins is Medical Director and Team Principal of Hair Restoration Blackrock. He was educated at Belvedere College Dublin and did his undergraduate medical studies at University College Dublin. After graduating as a doctor he trained in General Surgery and received his Fellowship (FRCSI) in this specialty from the Royal College of Surgeons in Ireland.

Find out more about DR Maurice Collins and our team of doctors and surgeons.